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Background: Serious mental illness (SMI) is associated with elevated mortality compared to the general population;
the majority of this excess is attributable to co-occurring common physical health conditions. There may be variation
within the SMI group in the distribution of physical co/multi-morbidity. This study aims to a) compare the pattern of
physical co- and multi-morbidity between patients with and without SMI within a South London primary care
population; and, b) to explore socio-demographic and health risk factors associated with excess physical morbidity
among the SMI group.
Methods: Data were obtained from Lambeth DataNet, a database of electronic patient records derived from general
practices in the London borough of Lambeth. The pattern of 12 co-morbid common physical conditions was compared
by SMI status. Multivariate ordinal and logistic regression analyses were conducted to assess the strength of association
between each condition and SMI status; adjustments were made for potentially confounding socio-demographic
characteristics and for potentially mediating health risk factors.
Results: While SMI patients were more frequently recorded with all 12 physical conditions than non-SMI patients, the
pattern of co-/multi-morbidity was similar between the two groups. Adjustment for socio-demographic characteristics –
in particular age and, to a lesser extent ethnicity, considerably reduced effect sizes and accounted for some of the
associations, though several conditions remained strongly associated with SMI status. Evidence for mediation by health
risk factors, in particular BMI, was supported.
Conclusions: SMI patients are at an elevated risk of a range of physical health conditions than non-SMI patients but they do
not appear to experience a different pattern of co-/multimorbidity among those conditions considered. Socio-demographic
differences between the two groups account for some of the excess in morbidity and known health risk factors are likely to
mediate the association. Further work to examine a wider range of conditions and health risk factors would help determine
the extent of excess mortality attributable to these factors.
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The UK policy paper, ‘No Health Without Mental Health’
published in 2011 [1] emphasised severe mental illness
across all of its six outcome objectives. The third objective
acknowledged that the physical health of people with se-
vere mental illness should be improved to address inequal-
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article, unless otherwise stated.Patients with severe mental illness (SMI) such as schizo-
phrenia and bipolar affective disorder die younger than
the background population [2-4]. This mortality gap has
been estimated at 10–18 years for women and 8–19 years
for men [2,4-6]. These excess deaths are largely attributed
to common physical disorders, most notably coronary
heart disease and stroke rather than ‘unnatural’ deaths
from violence or suicide [2,3,6-8]. The precise reasons for
this excess mortality have yet to be elucidated. There are a
range of inter-related risk factors including treatment-
related factors [9,10], health-related behaviours of patientstral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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this patient group, and the delivery of inferior healthcare
to those that do [13-15], and disease-related factors [16].
Behind the headline areas regarding mortality, patients
with SMI experience a range of chronic physical health
problems which may interfere with quality of life. Their
outcomes when they receive treatment are often poor.
Studies within secondary care are limited by their inabil-
ity to compare results with the non-SMI population. Yet
there are few large-scale primary care studies of the
physical health of patients with SMI with the exception
of Smith et al. [17].
Our study aims to extend previous work by looking in
detail at the physical health of an entire London bor-
ough. We aimed to investigate whether patterns of phys-
ical health comorbidity differed between patients with
and without SMI, and further, to examine the extent to
which this may be accounted for by individual factors, in
particular ethnicity.
Methods
The London borough of Lambeth is home to nearly
303100 residents and is the 29th most deprived borough in
the UK [18]. Lambeth is extremely diverse; data from the
2011 Census reveal it to have the highest proportion in
the country of: Portuguese and South American born
people; mixed race White and Black African people;
people from multiple mixed ethnic backgrounds; people
from non-Caribbean and non-African black backgrounds;
and, the second highest proportion of Black Caribbean
people in the country.
Data were extracted from the computerised medical
records of all except one GP practices (n = 48) within
Lambeth, as part of Lambeth DataNet (LDN) (the missing
GP practice has an incompatible IT system). LDN is a pri-
mary care database which collects anonymised data on GP
consultations, prescriptions, and Quality and Outcomes
Framework (QOF) data on clinical targets - as well as cer-
tain demographic information: age, gender, self-identified
ethnicity, and truncated postcode. LDN was started in
2004 as a local resource to improve ethnicity recording
and to explore local health inequalities, particularly those
based on ethnicity or social deprivation. LDN currently
covers a population of 366,317 registered patients. This
exceeds the total Lambeth population recorded in the
Census, likely due to the cross-boundary registration of
patients not living in Lambeth, list inflation, and the tem-
porary residence of students in the Lambeth area from
surrounding Universities.
Those with a serious mental illness (SMI) are identified
in LDN as part of the QOF initiative to include those with
bipolar affective disorder, schizophrenia and schizoaffec-
tive disorder, though data are not available to distinguish
between these diagnoses.Measures
Socio-demographic characteristics
Information was collected on: age, gender, ethnicity and
index of multiple deprivation score [18]. IMD scores were
divided into quintiles, such that comparisons were made
with the registered population of Lambeth rather than na-
tionally. Previous research within South East London has
found differences in mental health outcomes between eth-
nic groups that are often otherwise aggregated in analyses,
notably between Black Caribbean and Black African
groups [19]. Therefore the following sub-categories of eth-
nicity were examined: British/mixed British; Black African;
Back Caribbean; Asian/Asian British; mixed; other White;
other Black; and, other.
Physical health conditions
QOF requires GPs to keep a register of patients with a
number of long term health conditions indicated with bin-
ary (yes/no) variables. Of the 19 conditions covered by
QOF, 14 were available for the current study and 12 were
included in analyses. Dementia and depression were ex-
cluded due to the focus on physical health conditions and
potential overlap with SMI status. Conditions retained for
analysis were: hypertension (BP), epilepsy, diabetes melli-
tus (DM), coronary heart disease (CHD), chronic kidney
disease (CKD), chronic obstructive pulmonary disorder
(COPD), cancer (non-specified), atrial fibrillation, heart
failure, stroke, hypothyroidism, and asthma. Clinical areas
for which there was no available information were:
rheumatoid arthritis (introduced in the 2013/14 guide-
lines), osteoporosis, learning disability, and palliative care,
peripheral arterial disease. These outcomes were not in-
cluded in the database extraction used here.
Health risk factors
Data on patients’ Body Mass Index (BMI) and smoking
status were assessed. BMI scores were categorised into
‘underweight’ (BMI <18.5), ‘desirable’ (BMI 18.5-24.99),
‘overweight’ (BMI > =25), ‘obese’ (BMI > =30), and ‘mor-
bidly obese’ (BMI > =40). Smoking status was categorised
as ‘smoker’, ‘non-smoker’ and ‘ex-smoker’.
Statistical analyses
Analyses were carried out using STATA 11 (Stata
Corp, 2009). Patients aged below 16 years were ex-
cluded. Socio-demographic characteristics and individ-
ual health conditions were compared by SMI status
using multivariate logistic regression or with ordered
logistic regression analyses (BMI and smoking). All
models accounted for clustering by GP practice using
the cluster option.
Models were adjusted for socio-demographic charac-
teristics and health risk factors as appropriate; adjusted
odds ratios (OR) and 95% confidence intervals (CI) are
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Lemeshow’s goodness of fit test with the lfit command.
To investigate the pattern of health conditions experi-
enced by SMI status, individual health conditions were
listed and ranked according to the proportion of SMI
patients registered with each outcome. Values were then
graphically compared by SMI status, illustrating health
conditions (in the order of frequency determined by the
SMI group), against the proportion of the GP patient
population registered with each outcome.
Data summarising the combination of health condi-
tions registered for each patient were collapsed separ-
ately by SMI status; frequencies of discrete combinations
of conditions were generated and ordered from the most
to least frequent. The ten most frequent combinations
of health conditions are presented by SMI status.
Ethical approval
National Research Ethics Committee: concerning the use
of general practice data and practice specific quality in-
dicators. Chairman’s action.
Results
Among patients aged 16 years or more (n = 308,643),
1.41% were recorded with a serious mental illness (SMI).
Socio-demographic characteristics
SMI patients were more likely to be male and older than
non-SMI patients (mean age 48.7 years vs 40.6 years,
p < .001 (data not shown)). There was considerable
missing ethnicity data (~20%) yet substantially lower pro-
portion of SMI patients had their ethnicity reported as
‘unknown’ or ‘not stated’ than non-SMI patients (11.1%
vs. 19.0%, data not shown). Significant differences in SMI
status were found for ethnicity (p < .001). Specifically, a
greater proportion of ‘Black African’, ‘Black Caribbean’,
‘mixed’, and ‘other Black’ groups were identified with SMI
than ‘British/mixed British’ patients; this was particularly
pronounced among Black Caribbean’s, with over twice the
odds of being recorded with an SMI. ‘Other White’ and
‘other’ groups had lower odds of being recorded with an
SMI. Greater deprivation was positively associated with
SMI status (p < .001); nearly 35.9% of SMI patients were in
the most deprived quintile compared to 30.7% of non-SMI
patients (Table 1).
Health risk factors and behaviours
A lower proportion of SMI patients had missing data for
BMI and smoking status compared to non-SMI patients
(6.8% vs 23.0% and 0.9% vs 6.8% respectively, data not
shown). All BMI categories were associated with SMI
status, compared to the reference group (p < .001). Ad-
justment for ethnicity and age and to a slight extent,
deprivation, reduced the strength of association betweenSMI status and BMI; though the morbidly obese group
remained 2.5-fold more likely to be recorded with SMI
than the reference group (Table 2).
SMI status was significantly associated with being a
smoker or an ex-smoker (compared to non-smokers).
Adjustment for age and in particular, ethnicity, increased
the effect size for smokers but had only a slight impact
on that for ex-smokers compared to non-smokers, in
the opposite direction (with a reduction in effect size).
Patterns of co/multi-morbid health problems
Figure 1 illustrates the proportion of Lambeth patients
recorded with each physical condition by SMI status;
more common conditions on the left and rarer condi-
tions to the right. The graph suggests that SMI patients
are more commonly recorded with each condition but
that the pattern of prevalence is similar among the two
groups; the conditions do not differentially cluster in
SMI patients compared to non-SMI patients.
Similarly, the frequency with which discrete combina-
tions of physical health problems occurred were similar
for the first five most common comorbidity combina-
tions among SMI and non-SMI patients, though differ-
ences appeared in the subsequent five combinations
(Table 3).
Association between SMI status and physical health
SMI status was associated with over 2–3 fold greater
odds of being recorded with 1, 2 and 3+ health prob-
lems. Adjustment for age and to a lesser extent, ethni-
city, considerably reduced effect sizes. Age and ethnicity
demonstrated multiplicative effects such that the associ-
ation between SMI status and 3+ physical conditions
was rendered non-significant (p = 0.476) (Table 4).
To assess the extent to which health risk behaviours
may be a mechanism for excess comorbidity, further
analyses adjusted for smoking and BMI status. Adjust-
ment for BMI status (but not smoking) further reduced
effect sizes such that SMI status remained associated
only with having one recorded physical health condition,
compared to none (p = 0.018).
Individual conditions
SMI status was associated with greater odds of being re-
corded with every health outcome though adjustment
for socio-demographic characteristics markedly reduced
the effect sizes - rendering the associations between SMI
status and hypertension, asthma, coronary heart disease
(CHD), cancer, and atrial fibrillation non-significant. The
associations with hypertension and asthma were fully
accounted for by the inclusion of both age and ethnicity,
which demonstrated multiplicative effects. The associa-
tions with CHD, cancer and atrial fibrillation were fully
accounted for by age (Table 5).
Table 1 Socio-demographic characteristics of patients by SMI status
Non-SMI (16+ yrs) n = 304,297 SMI (16+ yrs) n = 4,346 Adjusted OR1
n % n % (95% CI)
Age group (years)
16-24 34718 11.4 146 3.4 1.00
25-34 94479 31.1 717 16.5 1.98 (1.63 - 2.41)***
35-44 72060 23.7 976 22.5 3.57 (2.94 - 4.32)***
45-54 49334 16.2 1118 25.7 5.63 (4.65 – 6.81)***
55-64 26419 8.7 679 15.6 6.65 (5.45 - 8.10)***
65+ 27287 9.0 710 16.3 5.95 (4.88 - 7.24)***
Sex
Female 148778 48.9 1914 44.0 1.00
Male 155500 51.1 2432 56.0 1.31 (1.23 - 1.40)***
Ethnicity (w/data)
British/mixed British 86815 35.2 1292 33.5 1.00
Black African 27429 11.1 514 13.3 1.19 (1.07 - 1.32)**
Black Caribbean 21206 8.6 789 20.4 2.11 (1.93 - 2.32)***
Asian/Asian British 18968 7.7 261 6.8 1.00 (0.87 - 1.14)
Mixed 11050 4.5 232 6.0 1.61 (1.40 - 1.86)***
Other White 65017 26.4 549 14.2 0.61 (0.55 - 0.68)***
Other Black 7275 3.0 167 4.3 1.60 (1.36 - 1.89)***
Other 8806 3.6 59 1.5 0.47 (0.36 - 0.61)***
IMD quintile (in Lambeth)
1st (least deprived) 61365 20.2 609 14.0 1.00
2nd 61316 20.2 806 18.6 1.39 (1.24 - 1.56)***
3rd 28723 9.4 449 10.3 1.60 (1.40 - 1.83)***
4th 59354 19.5 920 21.2 1.55 (1.39 - 1.74)***
5th (most deprived) 93539 30.7 1562 35.9 1.62 (1.46 - 1.79)***
Numbers (n), percentages (%), and adjusted odds ratios (OR) with 95% confidence intervals (CI) are shown.
1Adjusted for all other variables.
**p < .01 ***p < .001.
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may account for excess physical morbidity among SMI
patients, additional adjustments for smoking and BMI
status were made. This had a slight to moderate influ-
ence on effect sizes for COPD (driven by smoking), DM
(driven by BMI), hypothyroidism (driven by BMI), epi-
lepsy (driven by BMI and smoking) and heart failure
(driven by BMI and smoking) though all remained sig-
nificantly associated with SMI status. Adjustment for
BMI status (but not smoking) reduced the effect size of
blood pressure – such that SMI status became protective
against high blood pressure.
Model fit was assessed with Hosmer-Lemeshow tests.
Prior to addition of health risk behaviours, model fit was
adequate only for CHD, CKD, heart failure, atrial fibrilla-
tion and epilepsy (p > 0.05). For all conditions except
epilepsy, addition of health risk behaviours improved the
model fit such that model fit was adequate for all models(p > 0.05) except epilepsy (p < .001). The best fitting
model for epilepsy was that which included deprivation
score only (p = 0.770).
Of those conditions remaining associated with SMI
status, diabetes mellitus was the most commonly experi-




This study found that the pattern of physical co/multi-
morbidity among SMI patients did not differ from that
among non-SMI patients; nonetheless SMI patients were
at increased risk of being recorded with a range of phys-
ical health conditions, of being under or overweight, and
smoking. After adjustment for socio-demographics and
health risk behaviours, SMI status was associated with
having one comorbid physical condition compared to
Table 2 BMI group and smoking status by SMI status
Non-SMI (16+ yrs) n = 304,297 SMI (16+ yrs) n = 4,346 Unadjusted OR (95% CI) Adjusted OR1 (95% CI)
N % n %
BMI group
Underweight 8118 3.5 113 2.8 1.22 (1.01 - 1.47)* 1.29 (1.05 - 1.58)*
Desirable 116991 50.2 1337 33.3 1.00 1.00
Overweight 68312 29.3 1292 32.2 1.65 (1.50 - 1.83)*** 1.31 (1.18 - 1.45)***
Obese 35465 15.2 1105 27.5 2.73 (2.47 – 3.01)*** 1.95 (1.78 - 2.14)***
Morbidly obese 4260 1.8 171 4.3 3.51 (2.98 - 4.14)*** 2.63 (2.23 - 3.09)***
Smoking
Smoker 68188 24.1 1883 43.7 2.79 (2.51 – 3.10)*** 3.19 (2.86 - 3.55)***
Non-smoker 170365 60.1 1685 39.1 1.00 1.00
Ex-smoker 44942 15.9 737 17.1 1.66 (1.50 - 1.84)*** 1.55 (1.38 - 1.75)***
Numbers (n), percentages (%), and odds ratios (OR) with 95% confidence intervals (CI) are shown.
Ordinal logistic regression. CIs based on robust standard errors, clustered by GP practice.
*p < .05 ***p < .001.
1Adjusted for socio-demographic characteristics.
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Among individual conditions, adjustment for socio-
demographic factors (particularly age and ethnicity) and
BMI rendered associations between several physical con-
ditions and SMI status non-significant, and reversed the
association with hypertension. Significant elevated risks
of COPD, stroke, heart failure, chronic kidney disease,
hypothyroidism, diabetes and epilepsy among SMI pa-
tients remained. Of these conditions, epilepsy demon-
strated the strongest association with SMI status, while
diabetes was the most commonly experienced comorbid
condition among both SMI and non-SMI patients.
Comparison with previous research
The socio-demographic differences found here between
SMI and non-SMI patients are in line with previous stud-
ies using comparable data [17,20]; namely, SMI status was
associated with older age, male gender, and increasedFigure 1 Percentage (%) of SMI and non-SMI patients recorded with edeprivation. Non-white ethnicity is also an established risk
factor for SMI [21]. The prevalence of SMI found in the
current study (1.4%), is slightly higher than that reported
previously for the Lambeth primary care population (1.0%,
Pinto et al. [21]).
In a comparable study, Smith et al. [17] compared the
physical health of Scottish primary health care patients
with schizophrenia (SZ) or related non-organic psychoses
to those without and found a stronger association between
multimorbidity and SMI status even after adjusting for
deprivation. They also reported SMI patients to have 1, 2
and 3+ comorbid health conditions, likely due to the more
extensive range of health conditions considered (32 condi-
tions compared to 12 here).
The prevalence of each individual condition was slightly
lower among the Scottish study sample compared to that
reported here, with the exception of the two most com-
mon conditions – hypertension and diabetes – which,ach physical health condition.
Table 3 Ten most common patterns of co/multimorbid physical health problems by SMI status
Non-SMI SMI
1 Hypertension Hypertension
2 Asthma Diabetes Mellitus
3 Hypertension + Diabetes Mellitus Hypertension + Diabetes Mellitus
4 Diabetes Mellitus Asthma
5 Hypothyroidism Hypothyroidism
6 Cancer Chronic kidney disease
7 Hypertension + Chronic Kidney Disease Hypertension + Chronic kidney disease + Diabetes Mellitus
8 Hypertension + asthma Chronic obstructive pulmonary disease
9 Hypertension + Coronary heart disease Hypertension + Chronic kidney disease
10 Chronic obstructive pulmonary disease Epilepsy
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in this study (19% vs 16% and 13% vs 9% respectively). This
is likely due to ethnic differences between the samples; for
example diabetes and hypertension are more prevalent
among African Caribbean, Asian and Black African groups,
which constitute a greater proportion of the population of
Lambeth compared to Scotland. Other differences may
arise as the current study included outcomes that were
based on QoF recording. Since QoF outcomes are incenti-
vised, any bias may be expected to increase the recorded
prevalence of outcomes in our study. As we found that all
except two outcomes were less prevalent in our sample
than in the study by Smith et al. based on Read codes,
such bias would have led to an underestimation of the dif-
ference in the two samples and thus a more conservative
interpretation of the difference between the two samples.
Positive associations between SMI status and COPD,
thyroid disorders, diabetes and epilepsy were recorded in
both studies in regression analyses after adjustment for
socio-demographic status - though the associations were
stronger in the Lambeth sample despite additional adjust-
ment for ethnicity. Contrary to the current findings, they
report no difference in relation to heart failure, stroke or
CKD between the two groups; and, unlike the current
study, found cancer, CHD, and atrial fibrillation to beTable 4 Number of physical health conditions recorded for pa
Non-SMI (16+ yrs) n = 304,297 SMI (16+ yrs) n = 4,346
N % n %
No. health conditions
0 249177 81.9 2744 63.8
1 35161 11.6 897 20.6
2 12173 4.0 405 9.3
3+ 7786 2.6 270 6.2
Numbers (n), percentages (%), and adjusted odds ratios (OR) with 95% confidence
GP practice.
*p < .05 **p < .01 ***p < .001.
1Adjusted for age, sex, ethnic group, and IMD quintile.
2Additionally adjusted for smoking and BMI status.significantly less likely among cases. Lastly, hypertension
to be less likely after adjustment for socio-demographic
characteristics, a finding we replicated only after additional
adjustment for BMI.
These differences may be partly due to the differential
definition of cases; while they included only SZ and non-
organic psychoses, we used a composite measure which
also included bipolar affective disorder. Further, we adjusted
for ethnicity in addition to age, gender and deprivation.
This may have been more important in the current study,
given the high proportion of non-white ethnic groups in
Lambeth, compared to Scotland, in which according to
2011 Census data, over 95% of the population overall is
white. In this study, there was considerable ethnic variation
in both SMI status and prevalence of health conditions
considered. Ethnicity accounted for much of the association
of most health conditions with SMI status, though to a
lesser extent than age. Such differences are important to
consider in future studies among this population.
Previous research finds those with SMI at greater risk
of mortality than unaffected individuals, not accounted
for by excess suicide [3,8]. Recent large scale population
based studies find much of this excess mortality to be
associated with preventable physical health problems,
including cardiovascular diseases and cancer [2,4,8], astients by SMI status
Unadjusted OR Adjusted OR1 Adjusted OR2
(95% CI) (95% CI) (95% CI)
1.00 1.00 1.00
2.29 (2.07 - 2.54)*** 1.34 (1.21 - 1.49)*** 1.13 (1.02 - 1.25)*
2.99 (2.59 - 3.45)*** 1.27 (1.11 - 1.47)** 1.06 (0.92 - 1.22)
3.11 (2.60 - 3.74)*** 1.06 (0.90 - 1.25) 0.93 (0.78 - 1.10)
intervals (CI) are shown. CIs based on robust standard errors, clustered by
Table 5 Logistic regression analyses assessing the association between physical health conditions and SMI status





(95% CI)n % n %
BP 30977 10.2 829 19.1 2.08 (1.93 - 2.25)*** 0.99 (0.88 - 1.12) 0.85 (0.77 - 0.95)
DM 12321 4.1 560 12.9 3.51 (3.20 - 3.84)*** 2.04 (1.79 - 2.32)*** 1.77 (1.56 – 2.01)***
Asthma 13049 4.3 270 6.2 1.48 (1.31 - 1.67)*** 1.11 (0.96 - 1.29) 0.96 (0.82 - 1.11)
CKD 5487 1.8 212 4.9 2.79 (2.43 - 3.21)*** 1.57 (1.31 - 1.88)*** 1.55 (1.29 - 1.86)***
Thyroid 5393 1.8 182 4.2 2.42 (2.08 - 2.82)*** 1.73 (1.43 - 2.09)*** 1.60 (1.32 - 1.95)***
COPD 3243 1.1 126 2.9 2.77 (2.31 - 3.32)*** 1.71 (1.35 - 2.15)*** 1.27 (1.01 - 1.60)*
Stroke 3146 1.0 118 2.7 2.67 (2.22 - 3.22)*** 1.48 (1.17 - 1.87)** 1.44 (1.13 - 1.85)**
CHD 4927 1.6 112 2.6 1.61 (1.33 - 1.94)*** 0.94 (0.76 - 1.16) 0.85 (0.70 - 1.05)
Cancer 3867 1.3 76 1.8 1.38 (1.10 - 1.74)** 0.82 (0.65 - 1.03) 0.82 (0.65 - 1.04)
Epilepsy 1359 0.5 74 1.7 3.86 (3.05 - 4.89)*** 2.90 (2.30 - 3.66)*** 2.72 (2.12 - 3.51)***
HF 1427 0.5 53 1.2 2.62 (1.99 - 3.45)*** 1.54 (1.18 - 2.02)** 1.47 (1.09 - 1.97)*
AF 2065 0.7 41 0.9 1.39 (1.02 - 1.90)* 0.80 (0.56 - 1.15) 0.74 (0.49 - 1.13)
Unadjusted and adjusted odds ratios (OR) and 95% confidence intervals (CI) are shown. CIs based on robust standard errors, clustered by GP practice.
*p < .05 **p < .01 ***p < .001.
1Adjusted for age, sex, ethnic group and IMD quintile; 2Additionally adjusted for BMI and smoking status.
BP = hypertension; DM = Diabetes mellitus; CKD = Chronic kidney disease; COPD = Chronic obstructive pulmonary disease; CHD = Coronary heart disease;
HF = Heart failure; AF = Arial fibrillation.
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tory diseases [2,8].
The lack of difference found for CHD and atrial fibril-
lation in patients with and without SMI, and lower levels
of hypertension among SMI patients in the current
study, run counter to those findings. It may be inter-
preted that these outcomes are being underreported in
primary care [17]. Alternatively, this finding may be due
to excess mortality associated with CHD among the SMI
group. This explanation cannot be tested in the current
study due to the cross-sectional nature of the data, thus
can only provide data on prevalence (which is influenced
by both the duration of conditions and the incidence of
new cases). Cohort studies providing incidence data do
support this hypothesis; for example, Crump et al. [2] re-
port much higher mortality from ischaemic heart disease
(and cancer) but no increased risk of diagnoses with
these conditions among SMI patients; and, Osborn et al.
[20] report an excess of deaths from CHD and stroke
among SMI patients compared to control patients.
This study found that SMI patients were less likely to
have missing data for ethnicity, BMI and smoking status –
possibly suggesting that they do not have reduced access
to GP services. Previous research has found an elevated
consultation frequency among SMI patients which may
account for this finding [15]. Previous work suggests that
care offered to SMI patients may be inferior to those with-
out SMI [13]. This finding may also indicate lower con-
sultation rates among non-SMI patients. Future research
may elucidate whether the more comprehensive reporting
of BMI, ethnicity and smoking is due to greater frequency
of access to primary care among SMI patients in thissample; whether or not this translates into better record-
ing of health outcomes (and might account for some of
the elevated risk observed here); and, whether or not care
offered for physical problems reflects any greater access.Health risk behaviours
The impact of adjustment for lifestyle related variables –
smoking and BMI - on most conditions found to be associ-
ated with SMI status, supports previous research indicating
that excess morbidity and mortality is associated with sub-
optimal lifestyles [6,23]. The findings suggest that interven-
tions to reduce risk behaviours in this group may reduce
the risk associated with SMI status for physical health prob-
lems. Lifestyle interventions have been found to be effective
in the reduction of health risk behaviours [24,25], and to re-
duce mortality [26]. The remaining excess risk may be
partly accounted for by side effects of the use of anti-
psychotic medications and for genetic commonalities – e.g.
as is suggested for CVD risk factors [27].
Strengths and limitations
The strengths of this study lie in the large sample size and
the near complete coverage of GP data in the London bor-
ough of Lambeth. The study supports and extends previ-
ous findings by examining the pattern of comorbid health
conditions by SMI status. The main weaknesses pertain to
the cross-sectional nature of the data, the ability to gener-
alise findings beyond Lambeth and the lack of distinction
between SMI conditions despite known differences be-
tween BPD and SZ and other non-organic psychoses [23].
Further, the contribution of other health risk behaviours
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cohol consumption was not able to be elucidated.
Conclusions
In all, these data suggest that those with SMI are more
likely to be recorded with each condition rather than to
experience a different pattern of health conditions than
non-SMI patients, and that among the 12 health out-
comes included in the current study, the pattern of co/
multimorbid physical health problems is similar in SMI and
non-SMI patients. Consideration of socio-demographic dif-
ferences between SMI and non-SMI patients is important
in the assessment of excess physical morbidity among SMI
patients; in particular, age, and to a lesser extent, ethnicity.
Taking into account the cross-sectional nature of the
current study - if one considers the literature suggesting
that excess mortality is linked to excess physical comorbid-
ity - this study may indicate that having accounted for
socio-demographic factors - it is unlikely that cancer, hyper-
tension, coronary heart disease, or atrial fibrillation are re-
sponsible for the reduction in life expectancy among SMI
patients, though it is possible that under-diagnosis and/or
premature death due to these conditions may lead to an
underestimation of their prevalence among SMI patients.
Any specific effect of certain cancers, in particular lung
cancer that may be related to excess smoking among SMI
patients could not be assessed since a breakdown of cancer
diagnoses was not available. Of the conditions that
remained associated with SMI status following adjustment
for socio-demographic characteristics, only diabetes was
among the most common comorbid condition states iden-
tified, suggesting it may have an important role in explain-
ing the mortality gap. The study also suggests that health
risk behaviours may be influential mechanisms accounting
for excess morbidity, and further research addressing a
wider range of determinants (alcohol/drug use, exercise,
diet etc.) would help to determine the extent to which each
contributes to excess physical morbidity.
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